title: Factors contributing to successful discontinuation from inhaled nitric oxide therapy in pediatric patients after congenital cardiac surgery.
abstract: OBJECTIVE
  To investigate variables that contribute to successful discontinuation from inhaled nitric oxide (iNO) therapy in children after surgical repair of congenital heart disease.
  
  
  METHODS
  Analysis of retrospectively collected data.
  
  
  METHODS
  The pediatric intensive care unit of a university hospital.
  
  
  METHODS
  A total of 65 pediatric patients receiving iNO therapy for the purpose of pulmonary circulation control after cardiac surgery.
  
  
  METHODS
  None.
  
  
  RESULTS
  Patients were classified into two groups: those successfully weaned from iNO therapy on the initial attempt (group A, n = 45) and those for whom the initial attempt at weaning failed (group B, n = 20). Variables including intraoperative findings, postoperative hemodynamic and ventilatory variables, medication profiles, and dose and duration of iNO therapy were compared between groups. Using a multivariate logistic regression model, iNO therapy of >72 hrs (odds ratio, 5.6) and NO dose at discontinuation of <2 ppm (odds ratio, 4.1) were found to be significantly associated with successful weaning. Those results could be emphasized in a subgroup of left-to-right shunt cardiac anomaly.
  
  
  CONCLUSIONS
  Longer continuation (>72 hrs) and lower final concentration (<2 ppm) represent factors contributing to successful discontinuation of iNO therapy in pediatric patients after cardiac surgery, specifically for children with left-to-right shunt correction.
authors.affiliation: Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
authors.forename: Kyoko
authors.initials: K
authors.lastname: Kageyama
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Shime
authors.forename: Munetaka
authors.initials: M
authors.lastname: Hirose
authors.forename: Noriko
authors.initials: N
authors.lastname: Hiramatsu
authors.forename: Hiromi
authors.initials: H
authors.lastname: Ashida
authors.forename: Satoru
authors.initials: S
authors.lastname: Hashimoto
mesh_terms: D000280:Administration, Inhalation; D005260:Female; D006330:Heart Defects, Congenital / Q000601:surgery*; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000517:prevention & control*; D007223:Infant; D015278:Intensive Care Units, Pediatric; D007902:Length of Stay / Q000706:statistics & numerical data; D016015:Logistic Models; D008297:Male; D009569:Nitric Oxide / Q000008:administration & dosage*; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D009569:Nitric Oxide